Phase 3Withdrawn
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR): a Randomized Controlled Trial
- Sponsor
- The George Institute (Academic or other)
- Conditions
- Subarachnoid Hemorrhage; Subarachnoid Hemorrhage, Aneurysmal; Aneurysmal Subarachnoid Hemorrhage; Hemorrhage, Aneurysmal Subarachnoid
- Interventions
- Atorvastatin
- Ages
- adults, older adults
- Registry
- NCT06559072
Full record on ClinicalTrials.gov
From the registry
A researcher-initiated and conducted multicenter, randomized controlled trial aimed at evaluating the efficacy and safety of ultra-early statin therapy in the treatment of acute aneurysmal subarachnoid hemorrhage (aSAH).
Primary outcomes
- Utility-Weighted Modified Rankin Scale
History
Last registry update
Study completion
Primary completion
Started
Registered